Table 3.
Characteristics of bloodstream infections (n = 36) in 774 patients hospitalized with COVID-19
Characteristic | n (%) |
---|---|
Source | |
Central line | 17 (47.2) |
Skin | 6 (16.7) |
Pulmonary | 5 (13.9) |
Urine | 4 (11.1) |
Gastrointestinal | 3 (8.3) |
Unknown | 1 (2.8) |
Organism (n = 42)* | |
S. aureus | 7 (16.7) |
Candida species | 7 (16.7) |
Streptococcus species | 6 (14.3) |
Coagulase negative staphylococci | 5 (11.9) |
Enterococcus species | 5 (11.9) |
E. coli | 3 (7.1) |
Klebsiella species | 3 (7.1) |
Other gram-negative organisms† | 6 (14.3) |
Multidrug resistance (n = 42)* | |
None | 30 (71.4) |
Methicillin resistance | |
S. aureus | 4 (9.5) |
Coagulase-negative staphylococci | 2 (4.8) |
Vancomycin resistance | |
Enterococci | 3 (7.1) |
Carbapenem resistance | |
Enterobacterales | 2 (4.8) |
P. aeruginosa | 1 (2.4) |
Epidemiologic class‡ | |
Hospital-onset | 26 (72.2) |
Healthcare-associated, community-onset | 8 (22.2) |
Community-onset | 2 (5.6) |
Collection location | |
Intensive care unit | 24 (66.7) |
Emergency department | 10 (27.8) |
Ward | 2 (5.6) |
Outcomes | |
Persistent bloodstream infection§ | 0 |
Mortality (in-hospital) | 18 (50.0) |
Definition of abbreviations: COVID-19 = coronavirus disease; E. cloacae = Enterobacter cloacae; E. coli = Escherichia coli; P. aeruginosa = Pseudomonas aeruginosa; P. melaninogenica = Prevotella melaninogenica; P. mirabilis = Proteus mirabilis; S. aureus = Staphylococcus aureus; S. marcescens = Serratia marcescens.
Five patients had polymicrobial bacteremia; there were 42 total isolates.
Acinetobacter sp., E. cloacae, P. melaninogenica, P. mirabilis, P. aeruginosa, S. marcescens.
Using U.S. Centers for Disease Control and Prevention guidelines (15).
Positive blood cultures for the same organism at least 72 hours apart despite appropriate antibiotics.